Ngokusekelwe kumgomo wokubopha ngokuncintisana
Gcina njengoba kupakishwe esikhwameni esivaliwe ezingeni lokushisa (4-30℃ noma 40-86℉)
I-Lateral flow chromatographic immunoassay
Ikhithi yokuhlola esheshayo ye-Quality discovery AMRDT110
Ikhithi yokuhlola esheshayo ye-AMRDT110 iyi-lateral flow chromatographic immunoassay ukuze kutholwe ikhwalithi yezidakamizwa eziningi kanye nama-metabolite ezidakamizwa emchameni kulokhu kugxila okulandelayo:
| Isivivinyo | I-Calibrator | Ukusika (ng/mL) |
| I-Amphetamine (AMP1000) | I-D-Amphetamine | 1,000 |
| I-Amphetamine (AMP500) | I-D-Amphetamine | 500 |
| I-Amphetamine (AMP300) | I-D-Amphetamine | 300 |
| I-Benzodiazepines (BZO300) | I-Oxazepam | 300 |
| I-Benzodiazepines (BZO200) | I-Oxazepam | 200 |
| Ama-Barbiturates (BAR) | I-Secobarbital | 300 |
| I-Buprenorphine (BUP) | I-Buprenorphine | 10 |
| I-Cocaine (COC) | I-Benzoylecgonine | 300 |
| I-Cotinine (COT) | I-Cotinine | 200 |
| I-Methadone metabolite (EDDP) | 2-Ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine | 100 |
| I-Fentanyl (FYL) | I-Fentanyl | 200 |
| I-Ketamine (KET) | I-Ketamine | 1,000 |
| I-Synthetic Cannabinoid (K2 50) | JWH-018 5-pentanoic acid/ JWH-073 4-Butanoic acid | 50 |
| I-Synthetic Cannabinoid (K2 200) | JWH-018 5-pentanoic acid/ JWH-073 4-Butanoic acid | 200 |
| I-Methamphetamine (mAMP1000/ MET1000) | I-D-Methamphetamine | 1,000 |
| I-Methamphetamine (mAMP500/ MET500) | I-D-Methamphetamine | 500 |
| I-Methamphetamine (mAMP300/ MET300) | I-D-Methamphetamine | 300 |
| I-Methylenedioxymethamphetamine (MDMA) | D,L-Methylenedioxymethamphetamine | 500 |
| I-Morphine (MOP300/ OPI300) | I-Morphine | 300 |
| I-Methadone (MTD) | I-Methadone | 300 |
| I-Methaqualone (MQL) | I-Methaqualone | 300 |
| Ama-opiates (OPI 2000) | I-Morphine | 2,000 |
| I-Oxycodone (OXY) | I-Oxycodone | 100 |
| I-Phencyclidine (PCP) | Phencyclidine | 25 |
| I-Propoxyphene (PPX) | I-Propoxyphene | 300 |
| I-Tricyclic Antidepressants (TCA) | I-Notriptyline | 1,000 |
| Insangu (THC) | 11-nor-Δ9-THC-9-COOH | 50 |
| I-Tramadol (TRA) | I-Tramadol | 200 |
Ukulungiselelwa kwekhithi yokuhlola esheshayo ye-Qualitative discovery AMRDT110 ingaqukatha noma iyiphi inhlanganisela yabahlaziyi bezidakamizwa abasohlwini olungenhla.
I-Qualitative discovery test ngokushesha i-AMRDT110 iwukuhlolwa kokuzivikela komzimba okususelwe kumgomo wokubopha okuncintisanayo.Izidakamizwa okungenzeka zibe khona esibonelweni somchamo ziqhudelana nenhlanganisela yazo yezidakamizwa ukuze zibophe amasayithi ku-antibody yazo ethile.
Ngesikhathi sokuhlolwa, isampula yomchamo ihambela phezulu ngesenzo se-capillary.Umuthi, uma ukhona esifanekisweni somchamo ngaphansi kokugxila kwawo esikiwe, ngeke ugcwalise amasayithi okubopha ama-antibody awo athile.I-antibody izobe isisabela nge-conjugate ye-drug-protein futhi ulayini onombala obonakalayo uzovela esifundeni somugqa wokuhlola womugqa othile womuthi.Ukuba khona komuthi ngaphezu kokugxiliswa okunqunyiwe kuzogcwalisa zonke izingosi ezibophayo ze-antibody.Ngakho-ke, umugqa onemibala ngeke wakhe endaweni yomugqa wokuhlola.
Isampula somchamo onomuthi ngeke sikhiqize umugqa onemibala endaweni ethile yokuhlola yomugqa ngenxa yokuncintisana kwezidakamizwa, kuyilapho isifanekiso somchamo ongenawo umuthi sizokhiqiza umugqa endaweni yokuhlola ngenxa yokungabikho kokuncintisana kwezidakamizwa.
Ukuze usebenze njengesilawuli senqubo, umugqa onemibala uzohlala uvela endaweni yomugqa wokulawula, okubonisa ukuthi umthamo ofanele we-specimen wengeziwe futhi i-membrane wicking yenzekile.
Shiya Umlayezo Wakho:
-
Ikhithi Yokuhlola Esheshayo ye-COVID-19 Antigen AMRDT109
-
Ikhithi yokuhlola ye-COVID-19 ye-Saliva Antigen ye-AMDNA09
-
Imiphumela esheshayo emizuzwini eyi-15-30 Ikhithi ye-antigen esheshayo...
-
Ikhithi yokuhlola ye-lepu COVID-19 antigen AM...
-
Ikhithi ye-antigen ye-lepu eshibhile esheshayo i-AMRDT109 Plus
-
Ikhithi Yokuhlola Esheshayo ye-COVID-19 Antigen AMRDT109
